Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 215 followers
Latest posts
Last updated 27 days ago
Summary of opinion: Onivyde pegylated liposomal (previously known as Onivyde), 21/03/2024 Positive
27 days ago
Summary of opinion: Onivyde pegylated liposomal (previously known as Onivyde), 21/03/2024 Positive
Summary of opinion: Xtandi, 21/03/2024 Positive
27 days ago
Summary of opinion: Xtandi, 21/03/2024 Positive
Summary of opinion: Nustendi, 21/03/2024 Positive
27 days ago
Summary of opinion: Nustendi, 21/03/2024 Positive
Summary of opinion: Kalydeco, 22/02/2024 Positive
about 2 months ago
Summary of opinion: Kalydeco, 22/02/2024 Positive
Summary of opinion: Xromi, 22/02/2024 Positive
about 2 months ago
Summary of opinion: Xromi, 22/02/2024 Positive
Summary of opinion: Retsevmo, 25/01/2024 Positive
3 months ago
Summary of opinion: Retsevmo, 25/01/2024 Positive
Summary of opinion: Apexxnar, 25/01/2024 Positive
3 months ago
Summary of opinion: Apexxnar, 25/01/2024 Positive
Summary of opinion: Abecma, 25/01/2024 Positive
3 months ago
Summary of opinion: Abecma, 25/01/2024 Positive
Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 12, Status: Authorised
3 months ago
Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Libtayo, cemiplimab, Date of authorisation: 28/06/2019, Revision: 16, Status: Authorised
3 months ago
Human medicines European public assessment report (EPAR): Libtayo, cemiplimab, Date of authorisation...
Human medicines European public assessment report (EPAR): Flebogamma DIF (previously Flebogammadif), human normal immunoglobulin, Date of authorisation: 23/07/2007, Revision: 19, Status: Authorised
3 months ago
Human medicines European public assessment report (EPAR): Flebogamma DIF (previously Flebogammadif), human...
Human medicines European public assessment report (EPAR): Lokelma, sodium zirconium cyclosilicate, Date of authorisation: 22/03/2018, Revision: 10, Status: Authorised
3 months ago
Human medicines European public assessment report (EPAR): Lokelma, sodium zirconium cyclosilicate, Date...